Girancitug is a humanized IgG1κ monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
Girancitug
Copy Product Info
🥰Excellent
Catalog No. T9901A-1900
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
Girancitug
Cas No. 3024821-77-7
Pack Size
Price
USA Stock
Global Stock
Quantity
1 mg
Inquiry
Inquiry
Inquiry
5 mg
Inquiry
Inquiry
Inquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
Chemical Properties
Cas No.
3024821-77-7
Storage & Solubility Information
Storage
store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.
Calculator
Dilution Calculator
Reconstitution Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Girancitug | purchase Girancitug | Girancitug cost | order Girancitug